Skip to main content
Clinical Trials/NCT06824376
NCT06824376RecruitingNot Applicable

Efficacy and Safety Study of Manual Acupuncture (MA) on Serum Uric Acid (SUA) Outcomes in Patients With Asymptomatic Hyperuricemia (HUA): a Multi-center, Randomized, Sham-controlled Trial

Shenghao Tu1 site in 1 country260 target enrollmentStarted: March 25, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
260
Locations
1
Primary Endpoint
Serum uric acid (SUA)

Study Overview

Brief Summary

Assess the effectiveness of manual acupuncture in modulating serum uric acid levels among patients diagnosed with asymptomatic hyperuricemia.

Detailed Description

This is a multicenter randomized, single-blind, sham-controlled trial. A total of 260 eligible patients with asymptomatic hyperuricemia will be randomly assigned in a 1:1 ratio to manual acupuncture group or sham acupuncture group.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •With serum uric acid (SUA) level >7 mg/dL after 1 month of a low-purine diet.
  • •No history of gouty arthritis.
  • •Has not received uric acid-lowering drug treatment or stopped uric acid- lowering drug treatment ≥ 12 weeks.
  • •18.5kg/m2 ≤ body mass index (BMI) ≤ 30.0 kg/m
  • •Can write informed consent.

Exclusion Criteria

  • •Patients with poorly controlled hypertension: systolic blood pressure (SBP) ≥ 160mmHg, diastolic blood pressure (DBP) ≥ 100 mmHg.
  • •Patients with poorly controlled diabetes (hemoglobin A1c ≥ 8.4%).
  • •Patients with severe liver and kidney damage: chronic kidney disease (CKD) ≥ stage 2 or a serum creatinine, urea, alanine, or aspartate aminotransferase level more than twice of the upper limit.
  • •Patients with blood system diseases, such as acute and chronic leukemia, polycythemia, multiple myeloma, hemolytic anemia, lymphoma, or undergoing chemotherapy for multiple solid tumors.
  • •Patients with stroke, coronary heart disease, or severe neuropsychological diseases.
  • •Patients who are pregnant.
  • •Illiterate or unwilling to accept acupuncture treatment.

Arms & Interventions

Manual acupuncture group

Experimental

Acupuncturists will apply 20 sessions of 30-mintute manual acupuncture at 10 obligatory acupoints, over 8 weeks of treatment period.

Intervention: Manual acupuncture (Device)

Sham acupuncture group

Sham Comparator

20 sessions of non-penetrating sham acupuncture will be performed at non-acupuncture points, which are located on the back and with different segments from the kidney organ area,over 8 weeks of treatment period.

Intervention: Sham acupuncture (Device)

Outcomes

Primary Outcomes

Serum uric acid (SUA)

Time Frame: Baseline and 8 weeks after randomization.

Changes in the SUA level after 8 weeks of treatment.

Secondary Outcomes

  • Proportion of participants with SUA ≤ 6.0 mg/dL(4 weeks after randomization, 8 weeks after randomization, 12 weeks after randomization and 16 weeks after randomization.)
  • Proportion of participants with SUA ≤ 7.0 mg/dL.(4 weeks after randomization, 8 weeks after randomization, 12 weeks after randomization and 16 weeks after randomization.)
  • Dynamic changes in the SUA level after treatment.(Baseline, 4 weeks after randomization, 12 weeks after randomization and 16 weeks after randomization.)
  • The proportion of participants with gout attacks(4 weeks after randomization, 8 weeks after randomization, 12 weeks after randomization and 16 weeks after randomization.)

Investigators

Sponsor
Shenghao Tu
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Shenghao Tu

Professor

Tongji Hospital

Study Sites (1)

Loading locations...

Similar Trials